The contaminated syringes that led to more than 750 cases of fungal meningitis and 60 fatalities were produced by a compounding pharmacy. Such pharmacies existed largely outside of the regulatory authority of the Food and Drug Administration. The tragic outbreak and massive recall of the contaminated products caused legislators to seek ways of monitoring these types of drug manufacturers. President Barack Obama signed the Drug Quality and Security Act last Wednesday. The bill is intended to help prevent similar problems from occurring in the future.
New Laws For Compounding Pharmacies Following Meningitis Outbreak
FDA issues stronger warning of Topamax birth defect risk
New data has prompted the Food and Drug Administration to warn of an increased risk of cleft palette or cleft lip in infants born to mothers who are taking Topamax during the first trimester of pregnancy. Infants exposed to the drug during the first trimester are several times more likely to develop an oral cleft birth defect.
U.S. Senator Schumer Asks Food and Drug Administration To Publicly Distribute Data Showing A Possible Link Between Sunscreen Chemicals And Cancer
A recent study by the Environmental Working Group (EWG) has revealed a possible link between a chemical found in most popular sunscreens and the acceleration of the development of skin cancer, and United States Senator Charles Schumer wants the Food and Drug Administration (FDA) to release that information to the public.
